71 results
Page 2 of 4
8-K
EX-99.1
cgk8yfz zt
14 Mar 24
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
4:07pm
8-K
EX-99.1
3lrtfvi0
7 Feb 24
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
4:20pm
8-K
EX-99.1
gffderp0uf68x8yc
14 Nov 23
Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Updates
12:00am
8-K
EX-99.1
h2ct xtu4g
8 Aug 23
Terns Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Updates
4:24pm
8-K
EX-99.1
kcpng028tr3
3 Aug 23
Terns Pharmaceuticals Announces Leadership Transition
5:22pm
CORRESP
ehm559p
29 Jun 23
Correspondence with SEC
12:00am
UPLOAD
2e5w48d 412
22 Jun 23
Letter from SEC
12:00am
424B5
4t7lre
15 May 23
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
7xd7qf0fracepq0z19ga
15 May 23
Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates
8:30am
8-K
EX-99.1
nkguf1zbmtrrncsmoy
23 Dec 22
Terns Announces Pricing of $75 Million Public Offering
4:10pm
424B5
x5zr4vuuimf44nzi
21 Dec 22
Prospectus supplement for primary offering
4:22pm
424B5
bsysp0t
20 Dec 22
Prospectus supplement for primary offering
7:21am
8-K
EX-99.1
vqay5bd1tb1xl
9 Nov 22
Terns Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Highlights
4:18pm
8-K
EX-99.1
s3qxxp
16 Aug 22
Terns Announces $65 Million Oversubscribed Offering
5:18pm
424B5
a26biiys29hey6hcj9d
12 Aug 22
Prospectus supplement for primary offering
8:16am